Home > Boards > US Listed > Biotechs > Aclaris Therapeutics, Inc. (ACRS)

They filed a Confidential Treatment Order...

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Stock_Barber Member Profile
Member Level 
Followed By 234
Posts 29,856
Boards Moderated 17
Alias Born 08/19/09
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2019 5:53:24 PM
Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-502 Topical in Patients with Alopecia Areata Did Not Meet Endpoi... GlobeNewswire Inc. - 6/26/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:32:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2019 6:16:16 AM
Aclaris Therapeutics Announces Positive 6-Month Results from a Phase 2 Open-Label Clinical Trial of ATI-502 Topical in Patien... GlobeNewswire Inc. - 6/17/2019 6:00:00 AM
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/14/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 5:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:57:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:53:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:51:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:50:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:50:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 7:01:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2019 7:03:12 AM
Aclaris Therapeutics to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire Inc. - 5/24/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/13/2019 5:25:41 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/9/2019 4:59:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:05:05 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 4:17:37 PM
Aclaris Therapeutics Reports First Quarter 2019 Financial Results and Provides Update on Clinical and Commercial Developments... GlobeNewswire Inc. - 5/8/2019 4:01:00 PM
Aclaris Therapeutics to Announce First Quarter 2019 Financial Results on May 8, 2019 GlobeNewswire Inc. - 5/1/2019 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/25/2019 7:12:08 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 7:03:44 AM
Aclaris Therapeutics Submits Investigational New Drug Application for ATI-450, an oral MK2 inhibitor, for the Treatment of Rh... GlobeNewswire Inc. - 4/25/2019 7:00:00 AM
Aclaris Therapeutics Announces Issuance of a Patent Covering the use of Ruxolitinib and its Deuterated Forms to Treat Alopeci... GlobeNewswire Inc. - 4/24/2019 7:00:00 AM
Stock_Barber Member Level  Friday, 05/10/19 08:57:40 AM
Re: None
Post # of 4 
They filed a Confidential Treatment Order...

Don't see that very often!



Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist